Oelegem Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Oelegem Pharma
Largest movements
- Cash +€122,178
up €122,178 (+119%), from €102,582 to €224,759
mainly Other debts (+€248,124) and Net result for the year (+€237,016)
- Stocks and contracts +€65,795
up €65,795 (+27.9%), from €235,557 to €301,352
- Tangible fixed assets +€56,629
up €56,629 (+5.3%), from €1.1m to €1.1m
of which Plant, machinery and equipment: +€83,137
- Receivables within one year +€27,611
up €27,611 (+19.2%), from €143,505 to €171,116
of which Trade receivables: +€37,418
- Other debts +€248,124
up €248,124 (+73.2%), from €339,080 to €587,204
- Debts after one year -€76,156
down €76,156 (-10.6%), from €717,538 to €641,383
- Current portion of long-term debt +€45,952
up €45,952 (+152%), from €30,204 to €76,156
- Trade debts +€43,971
up €43,971 (+37.8%), from €116,469 to €160,441
- Gross operating margin +€53,379
up €53,379 (+10.9%), from €487,719 to €541,098
- Staff costs +€43,221
up €43,221 (+30.7%), from €140,937 to €184,158
- Depreciation +€40,470
up €40,470 (+125%), from €32,350 to €72,820
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,561,860 | €1,838,569 | +€276,710 | +17.7% |
| Fixed assets | 21/28 | €1,075,758 | €1,131,777 | +€56,020 | +5.2% |
| Intangible fixed assets | 21 | €2,371 | €1,761 | -€609 | -25.7% |
| Tangible fixed assets | 22/27 | €1,073,387 | €1,130,016 | +€56,629 | +5.3% |
| Land and buildings | 22 | €734,897 | €716,215 | -€18,682 | -2.5% |
| Plant, machinery and equipment | 23 | €329,266 | €412,402 | +€83,137 | +25.2% |
| Furniture and vehicles | 24 | €7,058 | €1,398 | -€5,659 | -80.2% |
| Other tangible fixed assets | 26 | €2,166 | €0 | -€2,166 | -100% |
| Current assets | 29/58 | €486,102 | €706,792 | +€220,690 | +45.4% |
| Stocks and contracts in progress | 3 | €235,557 | €301,352 | +€65,795 | +27.9% |
| Stocks | 30/36 | €235,557 | €301,352 | +€65,795 | +27.9% |
| Amounts receivable within one year | 40/41 | €143,505 | €171,116 | +€27,611 | +19.2% |
| Trade receivables | 40 | €133,698 | €171,116 | +€37,418 | +28.0% |
| Other amounts receivable | 41 | €9,807 | €0 | -€9,807 | -100% |
| Cash at bank and in hand | 54/58 | €102,582 | €224,759 | +€122,178 | +119% |
| Deferred charges and accrued income | 490/1 | €4,459 | €9,566 | +€5,107 | +115% |
| Total equity and liabilities | 10/49 | €1,561,860 | €1,838,569 | +€276,710 | +17.7% |
| Equity | 10/15 | €340,831 | €351,847 | +€11,016 | +3.2% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €173,508 | €173,508 | = | 0.0% |
| Distributable reserves | 133 | €173,508 | €173,508 | = | 0.0% |
| Profit (loss) carried forward | 14 | €67,323 | €78,339 | +€11,016 | +16.4% |
| Amounts payable | 17/49 | €1,221,028 | €1,486,722 | +€265,694 | +21.8% |
| Amounts payable after more than one year | 17 | €717,538 | €641,383 | -€76,156 | -10.6% |
| Financial debts | 170/4 | €717,538 | €641,383 | -€76,156 | -10.6% |
| Amounts payable within one year | 42/48 | €503,490 | €843,578 | +€340,088 | +67.5% |
| Current portion of amounts payable after more than one year | 42 | €30,204 | €76,156 | +€45,952 | +152% |
| Trade debts | 44 | €116,469 | €160,441 | +€43,971 | +37.8% |
| Suppliers | 440/4 | €116,469 | €160,441 | +€43,971 | +37.8% |
| Taxes, remuneration and social security | 45 | €17,736 | €19,777 | +€2,041 | +11.5% |
| Taxes | 450/3 | €91 | €1,105 | +€1,013 | +1,112% |
| Remuneration and social security | 454/9 | €17,645 | €18,673 | +€1,028 | +5.8% |
| Other amounts payable | 47/48 | €339,080 | €587,204 | +€248,124 | +73.2% |
| Accrued charges and deferred income | 492/3 | - | €1,762 | +€1,762 | |
| Remuneration, social security and pensions | 62 | €140,937 | €184,158 | +€43,221 | +30.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €32,350 | €72,820 | +€40,470 | +125% |
| Other operating charges | 640/8 | €598 | €1,157 | +€559 | +93.5% |
| Non-recurring operating charges | 66A | - | €5,651 | +€5,651 | |
| Gross operating margin | 9900 | €487,719 | €541,098 | +€53,379 | +10.9% |
| Operating profit (loss) | 9901 | €313,834 | €277,312 | -€36,522 | -11.6% |
| Financial income | 75/76B | €956 | €150 | -€807 | -84.3% |
| Recurring financial income | 75 | €956 | €150 | -€807 | -84.3% |
| Financial charges | 65/66B | €39,298 | €38,915 | -€383 | -1.0% |
| Recurring financial charges | 65 | €39,298 | €38,915 | -€383 | -1.0% |
| Profit (loss) for the period before taxes | 9903 | €275,493 | €238,547 | -€36,946 | -13.4% |
| Income taxes | 67/77 | €2,610 | €1,531 | -€1,079 | -41.3% |
| Profit (loss) for the period | 9904 | €272,883 | €237,016 | -€35,867 | -13.1% |
| Profit (loss) for the period to be appropriated | 9905 | €272,883 | €237,016 | -€35,867 | -13.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.